Market Tracker

08/26 5:16pm ET

Transition Therapeutics Inc (NASDAQ:TTHI)

1.49
Delayed Data
As of Aug 26
 +0.01 / +0.68%
Today’s Change
0.66
Today|||52-Week Range
2.75
-22.40%
Year-to-Date
No recent news for Transition Therapeutics Inc.

Today’s Trading

Previous close1.48
Today’s open1.51
Day’s range1.48 - 1.53
Volume20,667
Average volume (3 months)73,109
Market cap$57.8M
Dividend yield--
Data as of 3:50pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-78.76%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.97

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...-0.02-0.63%
GALTGalectin Therapeutic...-0.15-8.47%
VRMLVermillion Inc+0.01+0.76%
CGIXCancer Genetics Inc-0.01-0.43%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateSeptember 13, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$43.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
President &
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts